Skip to main content
Clinical Trials/NCT03320148
NCT03320148
Completed
Not Applicable

Determining the Impact of a New Physiotherapist Led Primary Care Model for Back Pain: A Pilot Cluster Randomized Controlled Trial

Queen's University1 site in 1 country100 target enrollmentSeptember 20, 2017
ConditionsBack Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Back Pain
Sponsor
Queen's University
Enrollment
100
Locations
1
Primary Endpoint
Recruitment of primary care teams
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This is a pilot cluster randomized controlled trial to determine the feasibility of a cluster randomized trial to evaluate the individual and health system impact of implementing a new physiotherapist-led primary care model for back pain in Canada.

Detailed Description

This study aims to determine the feasibility of conducting a cluster randomized trial in primary care settings in Ontario to evaluate the individual health outcomes and health system impact of implementing a new physiotherapist-led primary care model for people with back pain. The primary purpose of this pilot study is to determine the feasibility including recruitment and retention of primary care teams (sites) and patient participants, carrying out the assessment procedures, and implementing the physiotherapist-led primary care intervention including training the physiotherapist to adopt this role.

Registry
clinicaltrials.gov
Start Date
September 20, 2017
End Date
January 15, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jordan Miller, PT, PhD

Assistant Professor, School of Rehabilitation Therapy

Queen's University

Eligibility Criteria

Inclusion Criteria

  • Adults (18 years and over) with back pain of any duration
  • Seeking primary care for back pain at a participating site
  • Primary care visit may be a first or repeat visit

Exclusion Criteria

  • Patients who do not consent to participation
  • Patients who report being unable to understand, read, and write English

Outcomes

Primary Outcomes

Recruitment of primary care teams

Time Frame: Baseline

Ability to recruit four primary care teams (Family Health Teams or Community Health Centres) to paricipate

Recruitment of patient participants

Time Frame: Baseline to 14 weeks

Recruitment rate (participants/week) or total number of participants recruited in 14 weeks

Assessment completion

Time Frame: Baseline, 6-week 12-week, 6,9,12 month follow-up. The primary time point for this assessment is 12-week follow-up.

Percentage of all assessment items completed by participants completing each assessment

Retention of patient participants

Time Frame: Retention of participants at 6-week, 12-week, 6, 9, and 12-month follow-up assessments. The primary timeline for this outcome is 12-month follow-up.

Attrition rate

Physiotherapist confidence in carrying out the interventions

Time Frame: Baseline

The PT will rate his/her confidence in each component of the intervention after the training on a scale from 0-10 with higher scores indicating greater confidence in carrying out that component of the intervention.

Treatment fidelity

Time Frame: 6-week follow-up

Treatment fidelity will be measured by consistency with the intervention described in the protocol measured through an intervention checklist completed by the physiotherapist and an audit of the EMR notes.

Secondary Outcomes

  • Self-reported disability(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Self-reported pain intensity(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Health Related Quality of Life(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Global rating of change(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Satisfaction with health care(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Catastrophic Thinking(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Adverse events(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Health care accessibility(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Health care utilization(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Depressive symptoms(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Costs (piloted for a cost utility analysis in a future trial)(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Medications prescribed(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • Diagnostic imaging ordered(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • referrals to other health care providers made(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)
  • notes made by primary care provider to employers or insurers(Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up)

Study Sites (1)

Loading locations...

Similar Trials